Keywords: تیازولیدیدونها; ATP; Adenosine 5c-triphosphate; ALT; Alanine aminotransferase; aa; Amino acid; ASK1; Apoptosis signal- regulating kinase 1; AST; Aspartate aminotransferase; BASH; Both alcoholic and non-alcoholic liver disease; CCR2/CCR5; C-C chemokine receptor types 2 an
مقالات ISI تیازولیدیدونها (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تیازولیدیدونها; Atrial fibrillation; Diabetes mellitus; Insulin providers; Insulin sensitizers; Thiazolidinediones;
Keywords: تیازولیدیدونها; T2DM; type 2 diabetes mellitus; MetS; metabolic syndrome; IR; insulin resistance; HMW; high molecular weight; AMPK; 5â² adenosine monophosphate activated protein kinase; AdipoR; adiponectin receptor; PPARγ; peroxisome proliferator activated receptor γ;
Keywords: تیازولیدیدونها; 27-HC; 27-Hydroxycholesterol; 3PO; 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one; ABCG1; ATP-binding cassette subfamily G1; ACBA1; ATP-binding cassette subfamily A1; ACC1; Acetyl-Co-A carboxylase-1; AKAP4; A-kinase anchoring protein 4; ALDO; Aldolase; AM
Keywords: تیازولیدیدونها; Glucose-lowering drugs; Incretins; Insulin; Metformin; Na-glucose cotransport 2; Thiazolidinediones;
Keywords: تیازولیدیدونها; 25(OH)D; 25-hydroxyvitamin D; BMD; bone mineral density; BMI; body mass index; CLEC2B; C-type lectin domain family 2 member B; CRH; corticotropin-releasing hormone; CVs; coefficients of variation; DEGs; differentially expressed genes; FBS; fetal bovine se
Keywords: تیازولیدیدونها; DR1; direct repeat-1; ET-1; Endothelin-1; FA; fatty acid; FAO; fatty acid oxidation; HF; heart failure; NF-KB; nuclear factor kappa-B; PGC-1α; peroxisome proliferator activated receptor gamma co-activator 1 α; RXR; retinoid X receptor; SIRT1; silent inf
Keywords: تیازولیدیدونها; AGE; advanced glycation end products; AMPK; adenosine monophosphate-activated protein kinase; AngII; angiotensin II; CKD; chronic kidney disease; CRP; C-reactive protein; CT; computed tomography; DNA; deoxyribonucleic acid; ERS; extracellular-regulated pr
Keywords: تیازولیدیدونها; CVD; cardiovascular disease; CAD; coronary artery disease; T2DM; type II diabetes mellitus; ACEIs/ARBs; angiotensin converting enzyme inhibitors/angiotensin receptor blockers; RAAS; renin-angiotensin-aldosterone system; VSMC; vascular smooth muscle cell;
Keywords: تیازولیدیدونها; 2D QSAR; MLR; Hypoglycemic activity; Thiazolidinediones; Diabetes; Sucrose loaded model (SLM);
Keywords: تیازولیدیدونها; Cohort studies; Drug interactions; Hypoglycemia; Medicaid; Pharmacoepidemiology; Thiazolidinediones;
Keywords: تیازولیدیدونها; Thiazolidinediones; Endothelial cells; Inflammation; Angiogenesis;
Keywords: تیازولیدیدونها; Type 2 diabetes mellitus; Antidiabetic drugs; Cardiovascular safety; Cardiovascular disease; Cardiovascular outcome trials; A1C; glycated A1c hemoglobin; ACEi; angiotensin converting enzyme inhibitor; ACS; acute coronary syndrome; AHA; American heart asso
Keywords: تیازولیدیدونها; Metformin; Sulfonylureas; Thiazolidinediones; Gliptins; GLP-1; Neuroprotection;
Keywords: تیازولیدیدونها; Obesity; Nonalcoholic fatty liver disease (NAFLD); Nonalcoholic steatohepatitis (NASH); Thiazolidinediones; Pioglitazone; Diabetes; Insulin resistance;
Keywords: تیازولیدیدونها; GLUT; Glucose transporter; T1DM; Type-1 diabetes mellitus; T2DM; Type-2 diabetes mellitus; PKB/Akt; protein kinase B; GSK-3; glycogen synthase kinase-3; PGC-1α; peroxisome proliferator-activated receptor gamma coactivator-1α; FOXO; forkhead box O; VLDL;
Keywords: تیازولیدیدونها; Pioglitazone; Thiazolidinediones; Type 2 diabetes; Low dose; Insulin resistance
Keywords: تیازولیدیدونها; Lobeglitazone; Thiazolidinediones; Clinical trial; Randomised trial
Keywords: تیازولیدیدونها; Diabetes; Anaemia; B12; Ferritin; Metformin; G6PD; Gastritis; Coeliac disease; Addison's disease; Hypothyroidism; Hypogonadism; Erythropoietin; ACE inhibitors; Thiazolidinediones
Keywords: تیازولیدیدونها; RA; rheumatoid arthritis; DCs; dendritic cells; TolDCs; tolerogenic dendritic cells; NSAIDs; non-steroidal anti-inflammatory drugs; GC; glucocorticoids; DMARDs; disease-modifying anti-rheumatic drugs; TLRs; toll-like receptors; CLRs; cell surface C-type l
Keywords: تیازولیدیدونها; Diabetes mellitus; Cancer risk; Insulin; Antidiabetic drugs; ATP; adenosine triphosphate; BMI; body mass index; CI; confidence interval; DDDs; defined daily doses; DNA; deoxyribonucleic acid; DPP-4 inhibitors; dipeptidyl peptidase-4 inhibitors; Egr-1; ear
Keywords: تیازولیدیدونها; Diabetes mellitus; Cancer; Cohort study; Metformin; Sulfonylureas; Thiazolidinediones;
Keywords: تیازولیدیدونها; Thiazolidinediones; Glitazones; Glucose uptake activity; Rat hemi-diaphragm
Keywords: تیازولیدیدونها; Pioglitazone; Rosiglitazone; Thiazolidinediones; Fractures; Meta-analysis
Keywords: تیازولیدیدونها; Diabetes; Cancer; Insulin; Anti-diabetics; Cannabinoid; Obesity; 2-AG; 2-arachidonoyl glycerol; ACC; acetyl-CoA carboxylase; AMPK; adenosine monophosphate-activated protein kinase; CB1R; cannabinoid 1 receptor; CB2R; cannabinoid 2 receptor; CPT-1; carniti
Keywords: تیازولیدیدونها; ABCA; ATP-binding cassette transporter; AIM; Apoptosis inhibitor of macrophage; APC; antigen-presenting cell; ASC; apoptotic speck protein containing a caspase recruitment domain; AT; adipose tissue; ATM; AT macrophage; BLT; leukotriene B4 receptor; BM; b
Keywords: تیازولیدیدونها; ACAT; acyl-CoA cholesterol acyltransferase; ACC; acetyl CoA carboxylases; ACLY; ATP citrate lyases; ACSL; acyl CoA synthetases long chain family; ADRP; adipose differentiation related protein; AGP; advanced glycation end products; AGPAT; acylglycerophosph
Keywords: تیازولیدیدونها; Î2-TGZ; Î2-Troglitazone; TGZ; Troglitazone; TZD; Thiazolidinediones; RGZ; Rosiglitazone; 2-DG; 2-deoxyglucose; ER; endoplasmic reticulum; CGZ; Ciglitazone; UPR; unfolded protein response; Cancer; Glucose metabolism; 2-deoxyglucose, Thiazolidinediones; W
Keywords: تیازولیدیدونها; Thiazolidinediones; 1,2,3-Triazoles; Anticancer activity; α-Glucosidase inhibition; Molecular modeling study;
Keywords: تیازولیدیدونها; Afterhyperpolarization; Thiazolidinediones; Cognition; Imaging; Aging; Learning;
CMHX008, a PPARγ partial agonist, enhances insulin sensitivity with minor influences on bone loss
Keywords: تیازولیدیدونها; Osteoblasts; Peroxisome proliferator-activated receptor γ; Thiazolidinediones; TR-FRET; Type 2 diabetes mellitus;
A polyphenol-rich prebiotic in combination with a novel probiotic formulation alleviates markers of obesity and diabetes in Drosophila
Keywords: تیازولیدیدونها; Probiotic; Synbiotic; Gut microbiota; Diabetes; Obesity; TOR; ACC; acetyl CoA-carboxylase; Akt; Protein kinase B; AMPK; 5â²-adenosine monophosphate-activated protein kinase; Bi702255; Bifidobacteria longum spp. infantis NCIMB 702255; BMI; Body mass index
Design, synthesis, and evaluation of novel l-phenylglycine derivatives as potential PPARγ lead compounds
Keywords: تیازولیدیدونها; Diabetes mellitus; l-Phenylglycine; Tyrosine derivatives; Thiazolidinediones; Peroxisome proliferator-activated receptor; Dipeptidyl peptidase-4; α-Glucosidase;
Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes
Keywords: تیازولیدیدونها; Fatty Liver; NAFLD; Steatosis; Insulin Resistance; Thiazolidinediones; FFA; free fatty acid; NAS; nonalcoholic fatty liver disease activity score; NASH; nonalcoholic steatohepatitis; OGTT; oral glucose tolerance test; T2DM; type 2 diabetes mellitus;
Untying the knot of transcription factor druggability: Molecular modeling study of FOXM1 inhibitors
Keywords: تیازولیدیدونها; FOXM1; Thiostrepton; Thiazolidinediones; Troglitazone;
Design, synthesis and biological evaluation of novel thiazolidinedione derivatives as irreversible allosteric IKK-β modulators
Keywords: تیازولیدیدونها; IKK-β modulators; NF-κB signaling pathway; Thiazolidinediones; Allosteric modulation;
Using bisphenol A and its analogs to address the feasibility and usefulness of the CALUX-PPARγ assay to identify chemicals with obesogenic potential
Keywords: تیازولیدیدونها; Peroxisome proliferator-activated nuclear hormone receptor γ (PPARγ); CALUX; Obesogens; In vitro screening; Metabolism; Bisphenols; 15dPGJ2; 15-deoxy-Î12,14-prostaglandin J2; 3OH BDE-47; 3-hydroxy BDE-47; 5OH BDE-47; 5-hydroxy BDE-47; BADGE; Bisphenol
Heme oxygenase-1 induction by rosiglitazone via PKCα/AMPKα/p38 MAPKα/SIRT1/PPARγ pathway suppresses lipopolysaccharide-mediated pulmonary inflammation
Keywords: تیازولیدیدونها; Rosiglitazone (PubChem CID: 77999); Lipopolysaccharide (PubChem CID: 11970143); H7 (PubChem: 11957580); Gö6976 (PubChem: 3501); Compound C (PubChem: 11524144); p38VIII (PubChem: 9801969); Sirtinol (PubChem: 5717148); T0070907 (PubChem: 2777391); AMPKα;
Adipocytes spectrum - From homeostasia to obesity and its associated pathology
Keywords: تیازولیدیدونها; Acrp30 (AdipoQ); adiponectin gene; AdipoR; adiponectin receptor; AGE; angiotensinogen; ALP; alkaline phosphatase; Ang II; angiotensin II; Angptl2; angiopoietin-like protein-2; Aqp7; aquaporin-7; aP2; adipocyte-specific fatty acid binding protein 2 gene; A
Causes and solutions to “globesity”: The new fa(s)t alarming global epidemic
Keywords: تیازولیدیدونها; Obesity; Chronic low-grade inflammation; Pharmacotherapy; Novel targets; Medicinal plants; Clinical studies; Contents; 5HT2CR; Serotonin receptors subtype 2C; ACC; Acetyl-CoA carboxylase (EC 6.4.1.2); ACTH; Adrenocorticotropic hormone; AgRP; Agouti-relate
Pioglitazone improves insulin sensitivity and reduces weight loss in Walker-256 tumor-bearing rats
Keywords: تیازولیدیدونها; Cancer; Cachexia; Hypercatabolism; Insulin resistance; Metabolic changes; Thiazolidinediones;
Activation of PPARγ does not contribute to macrophage ABCA1 expression and ABCA1-mediated cholesterol efflux to apoAI
Keywords: تیازولیدیدونها; TZDs; ABCA1; CD36; Macrophages; Cholesterol efflux; ABCA1/G1; ATP-binding cassette transporter A1/G1; HDL; high-density lipoprotein; LXR; liver X receptor; PPARγ; peroxisome proliferator-activated receptor γ; TZDs; thiazolidinediones;
PPARs and nonalcoholic fatty liver disease
Keywords: تیازولیدیدونها; Liver; NAFLD; NASH; PPAR; Thiazolidinediones; Fibrates;
Novel 2,4- thiazolidinediones: Synthesis, in vitro cytotoxic activity, and mechanistic investigation
Keywords: تیازولیدیدونها; The glitazones; Thiazolidinediones; Anticancer; Apoptosis;
DBZ is a putative PPARγ agonist that prevents high fat diet-induced obesity, insulin resistance and gut dysbiosis
Keywords: تیازولیدیدونها; ACC; acetyl-CoA carboxylase; ADRB; adrenoreceptor beta; BAT; brown adipose tissue; CPT1β; carnitine palmitoyltransferase 1 beta; DBZ; danshensu bingpian zhi; Epi-WAT; epididymal white adipose tissue; FATP; fatty acid transport protein; FAS; fatty acid sy
Chronic LPSF/GQ-02 treatment attenuates inflammation and atherosclerosis development in LDLrâ/â mice
Keywords: تیازولیدیدونها; Atherosclerosis; Inflammation; LPSF/GQ-02; Thiazolidinediones;
ReviewAdiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review
Keywords: تیازولیدیدونها; Adiponectin; Nonalcoholic steatohepatitis; Pioglitazone; Rosiglitazone; Thiazolidinediones; ALT; Alanine transaminase; AST; Aspartate transaminase; BMI; Body mass index; ELISA; Enzyme-linked immunosorbent assay; HbA1c; Glycosylated hemoglobin; HOMA-IR; Ho
PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease
Keywords: تیازولیدیدونها; PPARγ; peroxisome proliferation-activated receptor gamma; 15D-PGJ2; 15-deoxy-Î12,14-Prostaglandin J2; TZDs; thiazolidinediones; CNS; central nervous system; WAT; white adipose tissue; BAT; brown adipose tissue; SRC; steroid receptor coactivator; CBP; CR
Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD)
Keywords: تیازولیدیدونها; NAFLD; Thiazolidinediones; LPSF/GQ-02; PPARα; AMPK and SREBP-1c;
New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLrâ/â mice
Keywords: تیازولیدیدونها; Atherosclerosis; Diabetes; Obesity; PPARγ; Thiazolidinediones;